Bifogade filer
Smart Eye Announces Breakthrough Agreement with European Police Authority for Drug Impairment Detection
Prenumeration
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Informationsteknik |
| Industri | Elektronisk utrustning |
Intresserad av bolagets nyckeltal?
Analysera bolaget i Börsdata!
Vem äger bolaget?
All ägardata du vill ha finns i Holdings!
The agreement marks the first time Smart Eye’s drug impairment detection technology will be deployed in a law enforcement setting. The deal comes through the newly acquired subsidiary Sightic.
GOTHENBURG, Sweden — March 25, 2026 — Smart Eye, the global leader in Human Insight AI, today announced that it has signed a multi-year agreement with a European police authority to deliver its AI-based drug impairment detection technology for use in law enforcement screening. The estimated order value is SEK 40 million over the contract period of four years, marking an important step in bringing this capability into real-world use.
The solution is based on technology developed by Sightic. It enables real-time, non-invasive screening of individuals to assess drug impairment. By evaluating eye movements, pupil response, and other behavioral signals, the system provides an objective indication of impairment. This allows officers to make faster, more informed decisions on whether further testing, such as blood analysis, is required. The solution is designed to support law enforcement in situations where rapid and reliable impairment assessment is critical.
“We have spent several years developing and validating this approach to impairment detection,” said Jenny Johansson, co-founder of Sightic. “Seeing it adopted by a law enforcement authority shows that it can deliver value in practical, high-stakes environments.”
“This is why we founded Sightic,” said Stefanie Najafi, co-founder of Sightic. “To create a way of assessing impairment that is objective, scalable, and usable in real-world situations where decisions need to be made quickly and reliably.”
The agreement follows Smart Eye’s recent acquisition of Sightic, which added advanced alcohol- and drug-impairment detection capabilities and one of the world’s largest real-world behavioral impairment datasets to Smart Eye’s technology portfolio. Together, the combined technologies enable broader and more robust impairment detection across multiple applications.
“This breakthrough order is of great importance,” said Martin Krantz, CEO and Founder of Smart Eye. “It opens up a new business vertical in a growing government sector with huge potential, with a TAM for Europe exceeding 1 billion SEK. If we can sell this to one police authority, we can sell it to many.”